These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas. Chen X; Pan C; Zhang P; Xu C; Sun Y; Yu H; Wu Y; Geng Y; Zuo P; Wu Z; Zhang J; Zhang L J Clin Neurosci; 2017 Dec; 46():50-57. PubMed ID: 28986151 [TBL] [Abstract][Full Text] [Related]
3. Intramedullary gangliogliomas: histopathologic and molecular features of 25 cases. Gessi M; Dörner E; Dreschmann V; Antonelli M; Waha A; Giangaspero F; Gnekow A; Pietsch T Hum Pathol; 2016 Mar; 49():107-13. PubMed ID: 26826417 [TBL] [Abstract][Full Text] [Related]
4. Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases. Donson AM; Kleinschmidt-DeMasters BK; Aisner DL; Bemis LT; Birks DK; Levy JM; Smith AA; Handler MH; Foreman NK; Rush SZ Brain Pathol; 2014 Mar; 24(2):173-83. PubMed ID: 24238153 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of Dabrafenib for three children with brainstem BRAF Philippe L; Maria K; Tariq A; Sofia M; Christine SM; Jean-Pierre F; Dudley RW; Sébastien P; Nada J; Valérie L J Neurooncol; 2019 Oct; 145(1):135-141. PubMed ID: 31502039 [TBL] [Abstract][Full Text] [Related]
6. Brainstem gangliogliomas: a retrospective series. Zhang S; Wang X; Liu X; Ju Y; Hui X J Neurosurg; 2013 Apr; 118(4):884-8. PubMed ID: 23373800 [TBL] [Abstract][Full Text] [Related]
9. Greater extent of resection improves ganglioglioma recurrence-free survival in children: a volumetric analysis. Haydon DH; Dahiya S; Smyth MD; Limbrick DD; Leonard JR Neurosurgery; 2014 Jul; 75(1):37-42. PubMed ID: 24625425 [TBL] [Abstract][Full Text] [Related]
10. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type. Ramaglia A; Tortora D; Mankad K; Lequin M; Severino M; D'Arco F; Löbel U; Benenati M; de Leng WWJ; De Marco P; Milanaccio C; Rossi A; Morana G Neuroradiology; 2020 Jan; 62(1):71-80. PubMed ID: 31667545 [TBL] [Abstract][Full Text] [Related]
11. Ganglioglioma of brain stem and cervicomedullary junction: A 50years review of literature. Janjua MB; Ivasyk I; Pisapia DJ; Souweidane MM J Clin Neurosci; 2017 Oct; 44():34-46. PubMed ID: 28687443 [TBL] [Abstract][Full Text] [Related]
12. MRI characteristics predict BRAF V600E status in gangliogliomas and pleomorphic xanthoastrocytomas and provide survival prognostication. Jiang B; Zheng Y; She D; Xing Z; Cao D Acta Radiol; 2024 Jan; 65(1):33-40. PubMed ID: 37401109 [TBL] [Abstract][Full Text] [Related]
13. The genetic landscape of ganglioglioma. Pekmezci M; Villanueva-Meyer JE; Goode B; Van Ziffle J; Onodera C; Grenert JP; Bastian BC; Chamyan G; Maher OM; Khatib Z; Kleinschmidt-DeMasters BK; Samuel D; Mueller S; Banerjee A; Clarke JL; Cooney T; Torkildson J; Gupta N; Theodosopoulos P; Chang EF; Berger M; Bollen AW; Perry A; Tihan T; Solomon DA Acta Neuropathol Commun; 2018 Jun; 6(1):47. PubMed ID: 29880043 [TBL] [Abstract][Full Text] [Related]
15. Central nervous system gangliogliomas. Part 2: Clinical outcome. Lang FF; Epstein FJ; Ransohoff J; Allen JC; Wisoff J; Abbott IR; Miller DC J Neurosurg; 1993 Dec; 79(6):867-73. PubMed ID: 8246055 [TBL] [Abstract][Full Text] [Related]
16. Autophagy-related protein expression was associated with BRAF V600E mutation in epilepsy associated glioneuronal tumors. Shen CH; Zhang YX; Xu JH; Zhu QB; Zhu JM; Guo Y; Ding Y; Wang S; Ding MP Epilepsy Res; 2017 Sep; 135():123-130. PubMed ID: 28667867 [TBL] [Abstract][Full Text] [Related]
17. The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Kim TY; Kim WB; Rhee YS; Song JY; Kim JM; Gong G; Lee S; Kim SY; Kim SC; Hong SJ; Shong YK Clin Endocrinol (Oxf); 2006 Sep; 65(3):364-8. PubMed ID: 16918957 [TBL] [Abstract][Full Text] [Related]
18. Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Chappé C; Padovani L; Scavarda D; Forest F; Nanni-Metellus I; Loundou A; Mercurio S; Fina F; Lena G; Colin C; Figarella-Branger D Brain Pathol; 2013 Sep; 23(5):574-83. PubMed ID: 23442159 [TBL] [Abstract][Full Text] [Related]
19. BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma. Dahiya S; Haydon DH; Alvarado D; Gurnett CA; Gutmann DH; Leonard JR Acta Neuropathol; 2013 Jun; 125(6):901-10. PubMed ID: 23609006 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological, Radiological, and Genetic Analyses of Cerebellar Gangliogliomas with Long-Term Survival. Liu B; Arakawa Y; Murata D; Mineharu Y; Yokogawa R; Tanji M; Fujimoto KI; Fukui N; Terada Y; Miyamoto S World Neurosurg; 2016 Oct; 94():521-528. PubMed ID: 27452969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]